Two different doses of Amitriptyline ER in the prophylaxis of migraine: Long-term results and predictive factors

European Journal of Neurology

Volumn 16, Issue 8, 2009, Pages 943-948

  Lampl, C ^a   Huber, G ^a   Adl, J ^a   Luthringshausen, G ^b   Franz, G ^c   Marecek, S ^d   Weber, J ^d   Baumhackl, U ^e   Mueller, T ^f  

^a KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^b PARACELSUS MEDICAL UNIVERSITY   (Austria)

^c Hospital Reutte   (Austria)

^d GENERAL HOSPITAL KLAGENFURT   (Austria)

^e Klinikum Mostviertel   (Austria)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Amitriptyline; Migraine; Prophylactic treatment

Indexed keywords

AMITRIPTYLINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DROWSINESS; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; FATIGUE; FEMALE; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL CONCENTRATION; MICTURITION DISORDER; MIGRAINE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SUSTAINED RELEASE FORMULATION; TREATMENT RESPONSE; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

ADULT; AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67651246841     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02631.x     Document Type: Article

References (16)

1. Goadsby PJ, Lipton RB, Ferrari MD. Migraine - current understanding and treatment. N Engl J Med 2002 346 : 257 270.
2. Silberstein S, Goadsby PJ. Migraine: preventive treatment. Cephalalgia 2002 22 : 491 512.
3. Silberstein SD for the US Headache Consortium. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000 55 : 754 762.
4. Evers S, Afra J, Frese A, et al. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol 2006 13 : 560 572.
5. Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis: changes in pattern of attacks during a controlled clinical trial. J Neurol Neurosurg Psychiatry 1973 36 : 684 690.
6. Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol 1979 36 : 695 699.
7. Ziegler DK, Hurwitz A, Hassanein RS, et al. Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol 1987 44 : 486 489.
8. Ziegler DK, Hurwitz A, Preskorn S, et al. Propranolol and amitriptyline in prophylaxis of migraine: pharmacokinetic and therapeutic effects. Arch Neurol 1993 50 : 825 830.
9. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004 24 (Suppl. 1 9 160.
10. Macedo A, Banos JE, Farre M. Placebo response in the prophylaxis of migraine: a meta-analysis. Eur J Pain 2008 12 : 68 75.
11. Van der Kuy PH, Lohman JJ. A quantification of the placebo response in migraine prophylaxis. Cephalalgia 2002 22 : 265 270.
12. Bendtsen L. Amitriptyline in the treatment of primary headaches. Expert Rev Neurother 2003 3 : 165 173.
13. Mathew NT. Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 1981 21 : 105 109.
14. Rafieian-Kopaei M, Mehvari J, Shirzadeh H. Different profile of propranolol and amitriptyline effects on migraine prophylaxis. Int J Pharmacol 2005 1 : 366 368.
15. Couch J. Amitriptyline in the Prophylactic Treatment of Headache. Poster Presentation to the 48th Annual Scientific Meeting of the American Headache Society. Los Angeles. June 22, 2006.
16. Lucetti C, Nuti A, Pavese N, et al. Flunarizine in migraine prophylaxis: predictive factors for a positive response. Cephalalgia 1998 18 : 349 352.